Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff Soule

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|January 25, 2018
Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in MiceLaura P van Lieshout, Geoff Soule, Debra Sorensen, et al.
Scientific Reports|September 1, 2021
Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster modelPatrycja Sroga, Angela Sloan, Bryce M Warner, et al.
JCI Insight|September 25, 2025
CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaquesJérémie Prévost, Nikesh Tailor, Geoff Soule, et al.
NPJ Vaccines|June 10, 2023
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigsWenguang Cao, Shihua He, Guodong Liu, et al.
The Journal of Infectious Diseases|August 6, 2016
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman PrimatesShipo Wu, Andrea Kroeker, Gary Wong, et al.
The Journal of Infectious Diseases|October 9, 2021
Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in MacaquesMarc Antoine de La Vega, Gary Wong, Haiyan Wei, et al.
Viruses|March 30, 2023
An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa VirusYvon Deschambault, Geoff Soule, Levi Klassen, et al.
Journal of Medical Microbiology|July 15, 2005
Identification and characterization of Shigella boydii 20 serovar nov., a new and emerging Shigella serotypeDavid L Woodward, Clifford G Clark, Richard A Caldeira, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challengeLaura P van Lieshout, Amira D Rghei, Wenguang Cao, et al.
Plos One|October 6, 2017
Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaquesHongzhao Li, Mikaela Nykoluk, Lin Li, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|January 25, 2018
Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in MiceLaura P van Lieshout, Geoff Soule, Debra Sorensen, et al.
Scientific Reports|September 1, 2021
Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster modelPatrycja Sroga, Angela Sloan, Bryce M Warner, et al.
JCI Insight|September 25, 2025
CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaquesJérémie Prévost, Nikesh Tailor, Geoff Soule, et al.
NPJ Vaccines|June 10, 2023
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigsWenguang Cao, Shihua He, Guodong Liu, et al.
The Journal of Infectious Diseases|August 6, 2016
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman PrimatesShipo Wu, Andrea Kroeker, Gary Wong, et al.
The Journal of Infectious Diseases|October 9, 2021
Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in MacaquesMarc Antoine de La Vega, Gary Wong, Haiyan Wei, et al.
Viruses|March 30, 2023
An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa VirusYvon Deschambault, Geoff Soule, Levi Klassen, et al.
Journal of Medical Microbiology|July 15, 2005
Identification and characterization of Shigella boydii 20 serovar nov., a new and emerging Shigella serotypeDavid L Woodward, Clifford G Clark, Richard A Caldeira, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challengeLaura P van Lieshout, Amira D Rghei, Wenguang Cao, et al.
Plos One|October 6, 2017
Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaquesHongzhao Li, Mikaela Nykoluk, Lin Li, et al.
Pageof 4